Delays in cancer registry reporting may have skewed the findings of the NordICC trial, which evaluated the long-term impact of screening colonoscopies. The trial, involving over 85,000 adults, excluded 221 participants with pre-existing colorectal cancer (CRC) that hadn’t yet appeared in registries—raising questions about the accuracy of reported outcomes. Researchers estimate that 2-3 year delays may have masked the true effectiveness of colonoscopies, showing a lower impact on CRC prevention than reality. If registration had been timely, risk reductions and outcomes could have been significantly better, suggesting a need for deeper investigation. What else might this delay reveal about the real power of colonoscopies?
Trending
- Cancer risk comparable across advanced IBD therapies in claims analysis (GI & Hepatology News)
- Independent practice on the road to extinction: Why the next generation won’t own the stethoscope, let alone the building (Medical Economics)
- Fecal Burden on CT Weakly Correlates with Bowel Function in Adults and is Poorly Associated with Clinical Symptoms (Digestive Diseases and Sciences)
- Cook Medical issues medical device correction for Hemospray Endoscopic Hemostat (AGA)
- Medicare physician pay reform 2027: Patients First Act and 4 other bills explained (Physicians Practice)
- FDA Advisory Committee Votes In Favor of Approval of GRAIL’s Galleri® Multi-Cancer Early Detection Test (PR Newswire)
- Batteries that safely break down in the GI tract could improve ingestible devices (Medical Xpress)
- Management of Obesity: Review of Adjunctive Therapies and Clinical Management Pearls (Gastroenterology)
